Esperion Therapeutics, Inc. (0IIM.L)

USD 2.27

(-8.85%)

Gross Profit Summary of Esperion Therapeutics, Inc.

  • Esperion Therapeutics, Inc.'s latest annual gross profit in 2023 was 73.06 Million USD , up 50.29% from previous year.
  • Esperion Therapeutics, Inc.'s latest quarterly gross profit in 2024 Q2 was 58.21 Million USD , down -54.4% from previous quarter.
  • Esperion Therapeutics, Inc. reported a annual gross profit of 48.5 Million USD in annual gross profit 2022, down -24.48% from previous year.
  • Esperion Therapeutics, Inc. reported a annual gross profit of 64.23 Million USD in annual gross profit 2021, down -71.47% from previous year.
  • Esperion Therapeutics, Inc. reported a quarterly gross profit of 127.66 Million USD for 2024 Q1, up 513.99% from previous quarter.
  • Esperion Therapeutics, Inc. reported a quarterly gross profit of 72.9 Million USD for 2023 FY, up 50.29% from previous quarter.

Annual Gross Profit Chart of Esperion Therapeutics, Inc. (2023 - 1999)

Historical Annual Gross Profit of Esperion Therapeutics, Inc. (2023 - 1999)

Year Gross Profit Gross Profit Growth
2023 73.06 Million USD 50.29%
2022 48.5 Million USD -24.48%
2021 64.23 Million USD -71.47%
2020 225.15 Million USD 926.35%
2019 -27.24 Million USD -114.79%
2018 184.2 Million USD 71498.84%
2017 -258 Thousand USD -2.38%
2016 -252 Thousand USD -6.78%
2015 -236 Thousand USD 0.0%
2014 - USD -100.0%
2013 4.97 Billion USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2002 - USD 0.0%
2001 - USD 100.0%
2000 -784 Thousand USD -14.75%
1999 -683.22 Thousand USD 0.0%

Peer Gross Profit Comparison of Esperion Therapeutics, Inc.

Name Gross Profit Gross Profit Difference
Editas Medicine, Inc. -99.52 Million USD 173.414%
Dynavax Technologies Corporation 182.11 Million USD 59.879%
Supernus Pharmaceuticals, Inc. 523.74 Million USD 86.049%
Perrigo Company plc 1.68 Billion USD 95.652%
Illumina, Inc. 2.74 Billion USD 97.337%
Thermo Fisher Scientific Inc. 15.22 Billion USD 99.52%
Iovance Biotherapeutics, Inc. -9.56 Million USD 863.82%
Walgreens Boots Alliance, Inc. 26.52 Billion USD 99.725%
IQVIA Holdings Inc. 5.23 Billion USD 98.605%
Heron Therapeutics, Inc. 10.04 Million USD -627.614%
Regeneron Pharmaceuticals, Inc. 11.3 Billion USD 99.353%
Unity Biotechnology, Inc. -19.69 Million USD 470.917%
Waters Corporation 1.76 Billion USD 95.851%
Biogen Inc. 7.3 Billion USD 98.999%
Sangamo Therapeutics, Inc. -45.32 Million USD 261.207%
Evolus, Inc. 140.52 Million USD 48.005%
Adicet Bio, Inc. -6.09 Million USD 1298.213%
Cara Therapeutics, Inc. 14.79 Million USD -393.896%
bluebird bio, Inc. -4.03 Million USD 1913.077%
FibroGen, Inc. 128.9 Million USD 43.317%
Agilent Technologies, Inc. 3.46 Billion USD 97.891%
Corbus Pharmaceuticals Holdings, Inc. -31.16 Million USD 334.432%
Homology Medicines, Inc. -7.22 Million USD 1110.748%
Geron Corporation -123.5 Million USD 159.162%
Alnylam Pharmaceuticals, Inc. 1.51 Billion USD 95.186%
Amicus Therapeutics, Inc. 362.03 Million USD 79.817%
Myriad Genetics, Inc. 476.4 Million USD 84.663%
Viking Therapeutics, Inc. -292 Thousand USD 25122.945%
Intellia Therapeutics, Inc. -398.79 Million USD 118.322%
Zoetis Inc. 5.83 Billion USD 98.748%
Abeona Therapeutics Inc. 302 Thousand USD -24094.371%
Mettler-Toledo International Inc. 2.16 Billion USD 96.631%
BioMarin Pharmaceutical Inc. 1.9 Billion USD 96.163%
Vertex Pharmaceuticals Incorporated 8.6 Billion USD 99.151%
Kala Pharmaceuticals, Inc. -303 Thousand USD 24214.521%
Ionis Pharmaceuticals, Inc. 778.51 Million USD 90.615%
Atara Biotherapeutics, Inc. -313 Thousand USD 23444.089%
Verastem, Inc. -62 Thousand USD 117950.0%
Nektar Therapeutics 53.47 Million USD -36.63%
Axsome Therapeutics, Inc. 244.53 Million USD 70.12%
Aclaris Therapeutics, Inc. -85.21 Million USD 185.743%
Sarepta Therapeutics, Inc. 1.09 Billion USD 93.315%
OPKO Health, Inc. 318.12 Million USD 77.032%
Exelixis, Inc. 1.75 Billion USD 95.843%
Neurocrine Biosciences, Inc. 1.84 Billion USD 96.045%
Corcept Therapeutics Incorporated 475.89 Million USD 84.646%
Anavex Life Sciences Corp. - USD -Infinity%
uniQure N.V. 2.21 Million USD -3198.736%
Imunon, Inc. -720 Thousand USD 10248.124%
Blueprint Medicines Corporation 236.58 Million USD 69.116%
Insmed Incorporated 239.63 Million USD 69.509%
Halozyme Therapeutics, Inc. 636.89 Million USD 88.528%
Agios Pharmaceuticals, Inc. 17.31 Million USD -321.889%
TG Therapeutics, Inc. 219.1 Million USD 66.653%
Incyte Corporation 3.44 Billion USD 97.876%
Emergent BioSolutions Inc. 343.9 Million USD 78.753%